Dana F. Durst

Executive Director, Site Activation & Regulatory Therapeutic Lead, Oncology

Dana F. Durst, Executive Director, Site Activation & Regulatory Therapeutic Lead, Oncology, at Worldwide Clinical Trials has more than 16 years of clinical research experience. Her experience ranges among a broad span of therapeutic areas including oncology, gene therapy, NASH, dermatology, ophthalmology, and cardiovascular studies extending from Phase I-IV. She has overseen all aspects of startup as well as maintenance activities in a variety of countries worldwide in both early and late phase trials, and with both small, agile clients and large clients.

Ask Dana a question

Submit an RFP. Ask a Question

Dana's passion within her leadership role is the management of her team and providing the guidance, knowledge, and support to be successful within their day to day. She prefers the mid-size CRO space where her, along with her team can be more flexible with customers and work collaboratively as one team.

Dana has a Bachelor’s in Communication degree from University of North Carolina at Wilmington.

Want to learn more about Worldwide Clinical Trials?